Oncovask Therapeutics is a California-based, scientist-led biotechnology company founded in 2024 to develop innovative and accessible technologies for precision cancer care.
Our multidisciplinary team brings together expertise in cancer biology, pharmaceutical sciences, drug formulation, mechanical and automation engineering, microfluidics, data science, artificial intelligence, and virtual reality. By integrating these disciplines, we are developing new approaches across three complementary areas: overcoming cancer therapy resistance, developing affordable microfluidic diagnostic technologies, and building AI-enabled digital-twin platforms to support personalized treatment decisions.
Our therapeutic research focuses on targeting difficult-to-drug DNA repair mechanisms that contribute to cancer treatment resistance, with an initial emphasis on restoring sensitivity to PARP inhibitors in resistant cancers. In parallel, we are developing microfluidic technologies for cancer detection and treatment monitoring and computational platforms designed to integrate patient and tumor data to support precision oncology.
Oncovask Therapeutics is registered to pursue U.S. federal small-business research funding opportunities, including the SBIR program, as we advance our technologies toward translational and commercial development.
Our goal is to bring together therapeutics, diagnostics, and digital technologies to make personalized cancer care more effective, accessible, and informed by each patient’s disease biology.
OUR GOAL IS CLEAR: TO ACCELERATE CANCER EARLY DETECTION, OVERCOME TREATMENT RESISTANCE, AND HARNESS AI FOR PERSONALIZED TREATMENT DECISIONS.
Mission & Vision
MISSION
VISION
OUR
EXPERTISE
CANCER EARLY DETECTION
Our expertise lies in pioneering early detection methods for cancer, facilitating timely intervention, and improving patient outcomes.
MOLECULAR CELL BIOLOGY
Molecular cell biology investigates how molecules govern cellular functions, shedding light on disease mechanisms and potential therapeutic targets.
Cancer therapy resistance
We unravel cancer therapy resistance mechanisms, developing novel approaches to enhance patient care.
CRISPR-Cas9 based therapy
Utilizing CRISPR-Cas9 technology, our therapy targets specific genetic sequences, offering precise and potentially curative treatments for a range of diseases.
COMMENTS FROM EXPERTS
Victoria Porter
CEO at Onconoma INCOncovask Therapeutics has truly revolutionized the landscape of cancer research. Their unwavering commitment to innovation and cutting-edge technologies is nothing short of inspiring. As a beacon of hope in the fight against cancer, Oncovask's breakthroughs are reshaping the future of cancer therapy, offering renewed possibilities for patients worldwide. Their dedicated team of experts showcases an unparalleled passion for advancing science and improving lives. It's an honor to witness the transformative impact they're making in the field, bringing us one step closer to conquering this formidable adversary.
Maria Flynn
CEO at Omniverse LLCOncovask Therapeutics has truly revolutionized the landscape of cancer research. Their unwavering commitment to innovation and cutting-edge technologies is nothing short of inspiring. As a beacon of hope in the fight against cancer, Oncovask's breakthroughs are reshaping the future of cancer therapy, offering renewed possibilities for patients worldwide. Their dedicated team of experts showcases an unparalleled passion for advancing science and improving lives. It's an honor to witness the transformative impact they're making in the field, bringing us one step closer to conquering this formidable adversary.
Gina Kennedy
CEO at VeriTech INCOncovask Therapeutics has truly revolutionized the landscape of cancer research. Their unwavering commitment to innovation and cutting-edge technologies is nothing short of inspiring. As a beacon of hope in the fight against cancer, Oncovask's breakthroughs are reshaping the future of cancer therapy, offering renewed possibilities for patients worldwide. Their dedicated team of experts showcases an unparalleled passion for advancing science and improving lives. It's an honor to witness the transformative impact they're making in the field, bringing us one step closer to conquering this formidable adversary.
Our EXPERT TEAM
Oncovask Therapeutics has a medical testing laboratory service that offers a complete range of tests for diagnosis, screening or evaluation.
Oncovask Therapeutics has a medical testing laboratory service that offers a complete range of tests for cancer diagnosis, screening or evaluation.
Oncovask Therapeutics has a medical testing laboratory service that offers a complete range of tests for diagnosis, screening or evaluation.
Meet Our Best Expert
